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Abstract
Background: Small for gestational age (SGA) infants are 
less likely to develop respiratory distress syndrome (RDS), 
but more likely to develop bronchopulmonary dysplasia 
(BPD) and have a higher mortality. Our aim was to focus 
on outcomes of those with a birth weight less than or 
equal to 750 g.
Methods: The mortality, BPD severity, necrotising entero-
colitis (NEC), home oxygen requirement and length of 
hospital stay were determined according to SGA status of 
all eligible infants in a 5-year period admitted within the 
first 24 h after birth.
Results: The outcomes of 84 infants were assessed, and 
35 (42%) were SGA. The SGA infants were more mature 
(P < 0.001), had a lower birth weight centile (P < 0.001) 
and a greater proportion exposed to antenatal corticos-
teroids (P = 0.022). Adjusted for gestational age (GA), 
there was no significant difference in mortality between 
the two groups (P = 0.242), but a greater proportion of the 
SGA infants developed severe BPD (P = 0.025). The SGA 
infants had a lower weight z-score at discharge (−3.64 vs. 
−1.66) (P = 0.001), but a decrease in z-score from birth to 
discharge was observed in both groups (median −1.53 vs. 
−1.07, P = 0.256).
Conclusions: Despite being more mature, the SGA infants 
had a similar mortality rate and a greater proportion 
developed severe BPD.
Keywords: bronchopulmonary dysplasia; extremely low 
birth weight; necrotising enterocolitis; small for gesta-
tional age.
Introduction
Small for gestational age (SGA) infants have been shown 
to be less likely to develop respiratory distress syndrome 
(RDS), possibly due to intra-uterine stress leading to accel-
erated lung maturation [1]. Other outcomes, however, 
appear to be worse for those born SGA, that is, having a 
birth weight below the tenth centile for their gestational 
age (GA) and sex [1–3]. Amongst infants born at less than 
or equal to 36 weeks of gestation, the SGA infants had a 
higher mortality, a significantly higher risk of developing 
chronic lung disease and a longer hospital stay [1]. Fur-
thermore, in infants born with a very low birth weight, 
the SGA group had increased risks of mortality and 
severe bronchopulmonary dysplasia (BPD) [2]. There has, 
however, been little focus on whether amongst infants 
with a birth weight less than or equal to 750 g, being born 
SGA influences mortality or morbidity. The aim of this 
study was to determine whether amongst such infants, 
those who were SGA had poorer outcomes than those who 
were born with a weight appropriate for their GA.
Materials and methods
A retrospective study of medical records and the BadgerNet Neonatal 
Electronic Patient Records at a tertiary neonatal intensive care unit 
(NICU) was undertaken. This study was undertaken as a clinical audit 
and as a consequence ethical approval was not required. All infants 
with a birth weight of 750 g or less, who were either born at or trans-
ferred to the hospital within the first 24 h after birth and admitted to 
the NICU for ongoing care between 2012 and 2016 were included in 
the study. Infants who died on the labour suite were not included.
Information extracted from the medical records included age at 
extubation, the occurrence of BPD, severe BPD and necrotising enter-
ocolitis (NEC), whether the infants had had naso-jejunal feeding, 
their weight at birth and discharge and the change in birth weight 
*Corresponding author: Professor Anne Greenough, Neonatal 
Intensive Care Centre, 4th Floor Golden Jubilee Wing, King’s College 
Hospital NHS Foundation Trust, Denmark Hill, London, SE5 9RS, UK; 
MRC-Asthma UK Centre in Allergic Mechanisms of Asthma, King’s 
College London, London, UK; Women and Children’s Health, School 
of Life Course Sciences, Faculty of Life Sciences and Medicine, 
King’s College London, London, UK; and National Institute for  
Health Research (NIHR) Biomedical Research Centre based at Guy’s 
and St Thomas’ NHS Foundation Trust and King’s College London, 
London, UK, Tel.: +0203 299 3037, Fax: +0203 299 8284,  
E-mail: anne.greenough@kcl.ac.uk
Elinor Charles, Katie A. Hunt and Christopher Harris: MRC-Asthma 
UK Centre in Allergic Mechanisms of Asthma, King’s College 
London, London, UK; and Women and Children’s Health, School of 
Life Course Sciences, Faculty of Life Sciences and Medicine, King’s 
College London, London, UK
Ann Hickey: Neonatal Intensive Care Centre, King’s College Hospital 
NHS Foundation Trust, London, UK
Brought to you by | King's College London
Authenticated
Download Date | 12/5/18 5:11 PM
2      Charles et al.: Small for gestational age outcomes
centile from birth to discharge and the cause of any mortality. BPD 
was defined as an ongoing oxygen requirement at 28  days of age. 
Those infants requiring positive pressure support or ≥30% oxygen at 
36 weeks post conceptional age were classified as having severe BPD 
[4]. NEC was diagnosed if there were both clinical signs (abdominal 
distension, abdominal discolouration, clinical instability, bilious 
aspirates and/or vomiting) and radiological abnormalities (pneu-
matosis intestinalis, gas in the hepato-biliary tract or a pneumop-
eritoneum) [5]. In addition, a surgical review had been undertaken 
and the infants had received a minimum of 5 days of treatment with 
antibiotics whilst being kept nil by mouth. Centiles and z-scores were 
calculated using UK World Health Organization (WHO) preterm refer-
ence ranges [6], and infants were divided into SGA and appropriate 
for gestational age (AGA) groups. SGA infants were defined as those 
below the tenth centile for sex and GA and AGA as those between the 
tenth and ninetieth centile.
Respiratory protocol
Infants of less than 32 weeks of GA who required intubation and ven-
tilation in the delivery room were started on a peak inflation pres-
sure (PIP) of 20–25 cm H2O, a positive end expiratory pressure (PEEP) 
of 4–5 cm H2O and a fraction of inspired oxygen (FiO2) of 0.21–0.30. 
They were given surfactant when stabilised. On transfer to the neo-
natal unit, they were ventilated on pressure-controlled time-cycled or 
assist-control ventilation using an SLE 5000 neonatal ventilator or an 
SLE 2000 infant ventilator (SLE, Croydon, UK). In the latter 2 years, 
volume-targeted ventilation was also used. All infants were venti-
lated with Cole’s shouldered endotracheal tubes which have been 
shown to have minimal or no leaks [7]. The supplementary oxygen 
was modified to achieve oxygen saturation levels between 92 and 
95%. Infants who required a PIP exceeding 25  cm H2O were trans-
ferred to high frequency oscillation. Extubation was attempted when 
the FiO2 was ≤30% and the PIP had been reduced below 18 cm H2O. 
Caffeine was commenced in the first 24 h. The nurses recorded hourly 
on observation charts, the level of respiratory support required by the 
infant. Infants were considered for supplementary oxygen at home 
when they had reached full oral feeds at 3 hourly intervals, but still 
required supplementary oxygen. They were sent home on supplemen-
tary oxygen if they were stable and had suitable home conditions.
Feeding protocol
Our feeding policy followed the East of England guidelines with 
clinician’s discretion exercised on increasing feeds in line with the 
protocol [8]. In the study population, colostrum was encouraged 
for mouth care from day 1. Trophic feeds (<20  mL/kg/day) were 
started as soon as mother’s milk was available and clinical stabil-
ity was achieved. If mother’s milk was not available and permission 
was given, donor milk was used. All of the infants in this study ful-
filled the criteria for donor milk as they were born at a GA of less 
than 32 weeks. For infants whose mothers did not provide maternal 
milk, donor milk was continued for 14–21  days, when a transition 
to preterm formula was made to promote growth. Parenteral nutri-
tion was commenced as early as possible post-delivery and standard 
bags were available out of hours. In infants with feed intolerance or 
dysmotility, concentrated parenteral nutrition at 50% of the total 
fluid intake was continued to ensure adequate calorie intake until 
growth and absorption were established. Using concentrated par-
enteral nutrition, up to 75% of calorie requirement can be given in 
50% of the fluid volume. Fortifier was added to the breast milk at the 
consultant’s discretion, when infants achieved feed volumes of 
150 mL/kg/day. Enteral feeds of 180 mL/kg/day of fortified maternal 
breast milk were aimed for in all infants. For formula-fed infants, 
volumes ranged from 150  mL/kg to 180  mL/kg depending on calo-
rie content and growth. Energy dense term formula, e.g. infatrini, 
was considered for those approaching term corrected age and whose 
intake was limited by ongoing respiratory distress associated with 
BPD. Naso-jejunal feeding was considered for infants where feeding 
advancement was limited by either respiratory disease or gastro-
oesophageal reflux. A multi-disciplinary nutrition team including 
a paediatric dietician and gastroenterologist reviewed all infants 
weekly to optimise nutrition and growth. Breastfeeding was actively 
encouraged by a dedicated NICU breast-feeding support worker; a 
specialised speech and language therapist was available.
Statistical analysis
The data were shown to be non-normally distributed and hence the 
Mann-Whitney U-test or chi-square (χ2) test was used as appropriate 
to assess whether differences in the demographics were statistically 
significant. Multiple linear regression or binary logistic regression as 
appropriate was used to adjust for differences in GA in the outcomes 
between the two groups. Statistical analysis was performed using 
IBM SPSS statistics version 24.
Results
Demographics
Thirty-five (42%) of the 84 infants in the study were SGA. 
The groups differed significantly at birth with regard to 
GA (P < 0.001), birth weight (P = 0.001) and birth weight 
z-score (P < 0.001) (Table 1). A greater proportion of 
the SGA infants had mothers who had hypertension 
(P ≤ 0.001), received antenatal steroids (P = 0.022), had 
abnormal umbilical Doppler results and had a caesar-
ean section delivery (P ≤ 0.001). All of the infants were 
intubated and ventilated in the delivery suite and given 
surfactant.
There were no significant differences in the mortality 
rate between the two groups (P = 0.242). Eleven infants of 
the SGA group died. Their causes of death were extreme 
prematurity/hypoxic respiratory failure (n = 7), respiratory 
failure secondary to BPD (n = 2), pulmonary haemorrhage 
(n = 1) and withdrawal of care following hypoxic brain 
injury after cardiac arrest (n = 1). Fifteen infants of the AGA 
group died. Their causes of death were extreme prematu-
rity/hypoxic respiratory failure (n = 7), respiratory failure 
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secondary to BPD (n = 3), pulmonary haemorrhage (n = 2), 
withdrawal of care following bilateral haemorrhagic 
parenchymal infarcts (n = 1), Pseudomonas sepsis (n = 1) 
and NEC (n = 1). All infants who survived to 36 weeks cor-
rected GA had BPD. A greater proportion of the SGA infants 
developed severe BPD (P = 0.025) (Table 2), but there was 
no significant difference in the length of hospital stay or 
in the proportions of the two groups who required home 
oxygen (Table 2).
The SGA infants had a significantly lower weight 
z-score at discharge (P = 0.001). A decrease in weight 
z-score from birth to discharge was observed in both 
groups and the change in weight z-score did not differ sig-
nificantly between the two groups (P = 0.256) (Table 3).
Table 1: Demographics according to SGA status.
SGA (n = 35) AGA (n = 49) P-Value
Antenatal corticosteroids 33 (94.3%) 38 (78%) 0.022
Maternal hypertension 17 (48.6%) 4 (8%) <0.001
Abnormal Dopplersa
 Normal 8 (23%) 33 (67%) <0.001
 Abnormal 25 (71%) 1 (2%)
Mode of delivery
 SVDb/instrumental 11 (31%) 45 (92%) <0.001
 Caesarean section 24 (69%) 4 (8%)
 Gestational age at birth, weeks 26.9 (23.4–31.9) 24.3 (22.3–26.7) <0.001
 Sex 21 (60%) 26 (53%) 0.528
 Birth weight, g 598 (450–732) 662 (510–750) 0.001
 z-Score at birth −2.22 (−3.64 to −1.38) −0.64 (−1.31 to +0.6) <0.001
 Birth centile 1 (0.05–8) 26 (10–73) <0.001
 Surfactant 35 (100%) 49 (100%)
The results are demonstrated as median (range) or n (%). aData were not available for all infants. bSpontaneous vaginal delivery.
Table 2: Mortality and respiratory morbidity according to SGA status.
  SGA (n = 35)   AGA (n = 49)   Odds ratio or risk estimate for 
95% confidence intervals
  P-Value adjusted for 
gestational age
Mortality   11 (31%)   15 (31.5%)   0.75 (0.60–7.40)   0.242
Age at death, days   36 (1–536)   14 (0–151)   40 (−80 to 160)   0.50
Severe BPDa   17 (70.8%)   22 (64.7%)   2.39 (1.35–88.26)   0.025
Length of hospital stay   126.5 (63–404)   130.5 (89–309)   53 (−2.29 to 81.09)   0.064
Home oxygen   16 of 24 (67%)   24 of 34 (71%)   1.32 (0.56–24.73)   0..173
The results are expressed as median (range) or n (%). aOf all infants surviving to 36 weeks of gestation.
Table 3: NICU course and discharge outcome.
SGA (n = 35) AGA (n = 49) Odds ratio or risk estimate 
(95% confidence interval)
P-Value adjusted for GA
NEC 8/35 (23%) 10/49 (20%) 0.5 (0.1–2.5) 0.349
Age at full enteral feeds, days 53.5 (26–172) 47.5 (11–184) 38.2 (9.1–67.2) 0.011
Required NJ feeding 3/35 (8.6%) 7/49 (14%) 2.3 (0.28–18.7) 0.443
Breastfeeding on discharge home 6/24 (25%) 12/34 (35%) 1.6 (0.33–8.0) 0.56
Any breast milk at discharge home 10/24 (42%) 20/34 (59%) 2.5 (0.57–10.6) 0.23
Length of hospital stay (days) in 
those surviving to discharge
126.5 (63–404) 130.5 (89–309) 39.4 (−2.2–81) 0.064
Weight z-Score at discharge −3.64 (−4.93 to −1.73) −1.66 (−4.91 to 0.65) −1.5 (−2.4 to −0.67) 0.001
Change in weight z-Score from birth 
to discharge
−1.53 (−4.01 to 0.54) −1.065 (−4.72 to 1.34) 0.47 (−0.35 to 1.30) 0.256
Data are presented as n (%) or median (range). NJ, naso-jejunal.
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Discussion
We have demonstrated that SGA infants were more likely 
to develop severe BPD than AGA infants (P = 0.025), 
despite being more mature at birth and a greater pro-
portion being exposed to antenatal corticosteroids. An 
increased risk of moderate to severe BPD (23% vs. 9%, 
respectively, P < 0.001) [9] was found in a study of infants 
born before 32  weeks of gestation amongst those with 
antenatal growth restriction compared to those without 
[9]. Furthermore, amongst infants born before 28 weeks of 
gestation, fetal growth restriction was highly predictive of 
BPD after adjustment for other risk factors [10]. Our study 
uniquely reports an increased risk of severe BPD in SGA 
infants with a birth weight less than 750 g. Fetal growth 
restriction in animal models has been reported to result in 
structural changes to the lungs, that is, fewer and larger 
alveoli and a thickened blood-air barrier [11, 12]. Proposed 
mechanisms include malnutrition [12, 13] and increased 
exposure to proinflammatory cytokines both pre- and 
immediately postnatally [14, 15]. Nevertheless, we did not 
demonstrate that the SGA infants compared to the AGA 
infants were more likely to require “home oxygen” which 
may reflect their greater maturity at birth.
We found no significant difference in the mortality 
rate between the two groups, even when adjusted for GA. 
This finding is supported by a previous report of no sig-
nificant difference in mortality between the SGA and AGA 
groups born between 26 and 28 weeks of GA [16], but they 
differed from our study population in that they had not 
been routinely exposed to antenatal steroids and postna-
tal surfactant. In contrast, in more mature infants, SGA 
has been frequently associated with an increased mortal-
ity [1, 2, 17].
The weight z-scores of infants born with a birth weight 
between 500 g and 749 g had been reported to fall by 1.10 
from admission to discharge [18]. In 2013, half of the pre-
mature infants born weighing less than 1500 g in North 
American hospitals were discharged with a weight under 
the tenth centile for their age [19]. Low GA, low birth 
weight, the need for assisted ventilation on the first day 
after birth and the development of BPD have all been inde-
pendently associated with poor growth [20, 21]. Although 
previous studies have suggested that SGA preterm infants 
experience a higher incidence of postnatal growth failure 
than AGA infants [22], we did not find this in our infants 
all who had a birth weight less than 750 g. Indeed, we 
did not find any significant difference in the changes in 
weight z-scores between AGA and SGA infants. We suggest 
our results may reflect a relatively aggressive nutritional 
policy.
Our study has strengths and some limitations. Previ-
ous studies have been criticised for failing to account for 
differences in GA and birth weight across cohorts and 
between comparison groups [1, 2]. We assessed the out-
comes of all infants with a birth weight less than 750 g. Our 
SGA group had a significantly higher median GA than our 
AGA group; we, therefore, adjusted for GA when determin-
ing the impact of being SGA at birth on outcomes. Whilst 
previous studies have focused on very low birth weight 
infants (<1500 g) and premature infants (<36 weeks), this 
is the first study to look specifically at the effect of SGA in 
the extremely low birth weight infant, i.e. a birth weight 
less than 750 g.
In conclusion, amongst infants with a birth weight 
less than or equal to 750 g, those born SGA despite being 
on average 2 weeks more mature, had a similar mortality 
rate to the AGA infants. In addition, a greater proportion 
of the SGA infants had severe BPD and a similar length 
of stay to the AGA infants. These results should help to 
inform counselling of parents expecting an SGA, prema-
turely born infant.
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